H.R.1806 - Triple-Negative Breast Cancer Research and Education Act of 2025
119th Congress (2025-2026)
congress.gov/bill/.format=txt
Bottom of that April 2021 grant that included RP:
Partial funder NIH
Breakthrough Breast Cancer Research Program
(3)
(1)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-